| scholarly article | Q13442814 |
| P2093 | author name string | G Alexander Patterson | |
| Sabarinathan Ramachandran | |||
| Thalachallour Mohanakumar | |||
| Aviva Aloush | |||
| Elbert Trulock | |||
| Trudie A Goers | |||
| P2860 | cites work | IL-6DBP, a nuclear protein involved in interleukin-6 signal transduction, defines a new family of leucine zipper proteins related to C/EBP | Q28575310 |
| Vascular endothelial growth factor in human lung transplantation | Q31828748 | ||
| Chronic humoral rejection: identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries | Q31961631 | ||
| Proteomic surveillance of autoantigens in relapsing polychondritis. | Q33234402 | ||
| Anti-HLA antibodies after solid organ transplantation | Q33856062 | ||
| Clinical importance of HLA-specific and non-HLA-specific antibodies in allogeneic kidney transplantation | Q34078201 | ||
| Evidence for immune responses to a self-antigen in lung transplantation: role of type V collagen-specific T cells in the pathogenesis of lung allograft rejection | Q34140501 | ||
| The role of HLA class I and class II antibodies in renal transplantation. | Q34377619 | ||
| Immune mechanisms in the pathogenesis of bronchiolitis obliterans syndrome after lung transplantation | Q34387549 | ||
| Current trends in lung transplantation | Q34725194 | ||
| The role of autoimmunity in the pathogenesis of lung allograft rejection. | Q35212101 | ||
| Anti-HLA antibody analysis and crossmatching in heart and lung transplantation | Q35808818 | ||
| Lung transplantation: opportunities for research and clinical advancement | Q36195432 | ||
| Bronchiolitis obliterans following lung transplantation | Q36630455 | ||
| Anti-vimentin antibodies are an independent predictor of transplant-associated coronary artery disease following cardiac transplantation | Q74605974 | ||
| Temporal relationship between the development of anti-HLA antibodies and the development of bronchiolitis obliterans syndrome after lung transplantation | Q74615948 | ||
| Target antigens of post-rejection non-HLA antibodies in renal transplantation | Q77325598 | ||
| Development of ELISA-detected anti-HLA antibodies precedes the development of bronchiolitis obliterans syndrome and correlates with progressive decline in pulmonary function after lung transplantation | Q77415463 | ||
| Specific immune responses against airway epithelial cells in a transgenic mouse-trachea transplantation model for obliterative airway disease | Q79162194 | ||
| HLA-specific antibodies are risk factors for lymphocytic bronchiolitis and chronic lung allograft dysfunction | Q81239058 | ||
| Vimentin antibodies: a non-HLA antibody as a potential risk factor in renal transplantation | Q81680338 | ||
| Impact of ELISA-detected anti-HLA antibodies on pediatric cardiac allograft outcome | Q81814057 | ||
| Acute and chronic rejection after lung transplantation | Q36638083 | ||
| Induction of autoimmunity after allotransplantation | Q36814004 | ||
| Elevated levels of interleukin-8 and transforming growth factor-beta in bronchoalveolar lavage fluid from patients with bronchiolitis obliterans syndrome: proinflammatory role of bronchial epithelial cells. Munich Lung Transplant Group | Q38309643 | ||
| CCAAT/enhancer binding protein beta mediates the activation of the murine alpha1(I) collagen promoter by acetaldehyde | Q38311034 | ||
| Dual role of vascular endothelial growth factor in experimental obliterative bronchiolitis. | Q38329140 | ||
| Anti-HLA class I antibody binding to airway epithelial cells induces production of fibrogenic growth factors and apoptotic cell death: a possible mechanism for bronchiolitis obliterans syndrome | Q38355651 | ||
| Immunologic monitoring in lung allograft recipients | Q38362456 | ||
| Growth factor upregulation during obliterative bronchiolitis in the mouse model | Q38363842 | ||
| Activation of human airway epithelial cells by non-HLA antibodies developed after lung transplantation: a potential etiological factor for bronchiolitis obliterans syndrome | Q40806790 | ||
| Clinical aspects of lung transplantation. | Q40921277 | ||
| The bronchial epithelium: a potential allogeneic target for chronic rejection after lung transplantation. | Q41187602 | ||
| Matching for MHC haplotypes results in improved survival following unrelated bone marrow transplantation. | Q41366540 | ||
| The clinical significance of post-transplantation non-HLA antibodies in renal transplantation | Q41399958 | ||
| De novo autoimmunity to cardiac myosin after heart transplantation and its contribution to the rejection process | Q41669066 | ||
| Ischemia induces early changes to cytoskeletal and contractile proteins in diseased human myocardium | Q41675602 | ||
| Novel antibodies associated with unexplained loss of renal allografts | Q41728992 | ||
| Early posttransplant inflammation promotes the development of alloimmunity and chronic human lung allograft rejection | Q42507629 | ||
| Pathologic correlates of bronchiolitis obliterans syndrome in pulmonary retransplant recipients | Q44030374 | ||
| Pre-transplant panel reactive antibody in lung transplant recipients is associated with significantly worse post-transplant survival in a multicenter study | Q44736975 | ||
| Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome | Q45023842 | ||
| Steroid-responsive bronchiolitis after human heart-lung transplantation | Q45236765 | ||
| Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection | Q45259438 | ||
| Interleukin-1 beta induction of matrix metalloproteinase-1 transcription in chondrocytes requires ERK-dependent activation of CCAAT enhancer-binding protein-beta | Q46924029 | ||
| Immunologic risk factors and glomerular C4d deposits in chronic transplant glomerulopathy | Q47588333 | ||
| Airway vascular changes after lung transplant: potential contribution to the pathophysiology of bronchiolitis obliterans syndrome | Q47714857 | ||
| Airway epithelium is the primary target of allograft rejection in murine obliterative airway disease. | Q48020074 | ||
| Fibroblast growth factor-2 expression is up-regulated after denervation in rat lung tissue | Q48591050 | ||
| HLA-A locus mismatches and development of antibodies to HLA after lung transplantation correlate with the development of bronchiolitis obliterans syndrome. | Q50899711 | ||
| HLA-specific antibodies are associated with high-grade and persistent-recurrent lung allograft acute rejection. | Q53283790 | ||
| Role of airway epithelial injury in murine orthotopic tracheal allograft rejection. | Q53588287 | ||
| Anti-Type V Collagen Lymphocytes that Express IL-17 and IL-23 Induce Rejection Pathology in Fresh and Well-Healed Lung Transplants | Q61884128 | ||
| A polymorphic human kidney-specific non-MHC alloantigen. Its possible role in tissue-specific allograft immunity | Q67535759 | ||
| Vascular deposition of complement-split products in kidney allografts with cell-mediated rejection | Q67773387 | ||
| Regulation of major histocompatibility complex class II gene expression on bovine bronchial epithelial cells | Q68172218 | ||
| Crossmatch with donor skin: characterization of alloantibodies and correlation with early kidney rejection | Q68188192 | ||
| Atypical changes of respiratory epithelium after heart-lung transplantation. A case report | Q69213999 | ||
| The role of MHC and non-MHC antigens in the rejection of intracerebral allogeneic neural grafts | Q69400999 | ||
| Chronic rejection in lung allografts: immunohistological analysis of fibrogenesis | Q71873744 | ||
| Are multiple immunopathogenetic events occurring during the development of obliterative bronchiolitis and acute rejection? | Q72081425 | ||
| Importance of bronchus-associated lymphoid tissue and major histocompatibility complex class I and class II antigen expression on bronchial epithelium in acute lung allograft rejection and lung infection in rats | Q72142358 | ||
| Complement activation in acute humoral renal allograft rejection: diagnostic significance of C4d deposits in peritubular capillaries | Q73039869 | ||
| Detection of humoral rejection in human cardiac allografts by assessing the capillary deposition of complement fragment C4d in endomyocardial biopsies | Q73100253 | ||
| Complement activation by anti-endothelial cell antibodies in MHC-mismatched and MHC-matched heart allograft rejection: anti-MHC-, but not anti non-MHC alloantibodies are effective in complement activation | Q73125229 | ||
| Anti-cell surface endothelial antibodies in sera from cardiac and kidney transplant recipients: association with chronic rejection | Q73231144 | ||
| Susceptibility of lung transplants to preformed donor-specific HLA antibodies as detected by flow cytometry | Q73253914 | ||
| Human alveolar epithelial cells type II are capable of regulating T-cell activity | Q73494071 | ||
| Effects of antibody reactivity to major histocompatibility complex (MHC) and non-MHC alloantigens on graft endothelial cells in heart allograft rejection | Q73832055 | ||
| Development of anti-tissue antibodies in the rat liver transplant model | Q74535279 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibody | Q79460 |
| P304 | page(s) | 4487-4494 | |
| P577 | publication date | 2008-04-01 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | De novo production of K-alpha1 tubulin-specific antibodies: role in chronic lung allograft rejection | |
| P478 | volume | 180 |
| Q37044200 | A role for antibodies to human leukocyte antigens, collagen-V, and K-α1-Tubulin in antibody-mediated rejection and cardiac allograft vasculopathy |
| Q82761069 | A shift in the collagen V antigenic epitope leads to T helper phenotype switch and immune response to self-antigen leading to chronic lung allograft rejection |
| Q39470034 | A stepwise breakdown of B-cell tolerance occurs within renal allografts during chronic rejection |
| Q35646152 | Acute Antibody-Mediated Rejection in Presence of MICA-DSA and Successful Renal Re-Transplant with Negative-MICA Virtual Crossmatch |
| Q41953105 | Acute allograft rejection: cellular and humoral processes |
| Q37365017 | Acute rejection and humoral sensitization in lung transplant recipients |
| Q34080563 | Alloimmunity and autoimmunity in chronic rejection |
| Q34970022 | Alloimmunity-induced autoimmunity as a potential mechanism in the pathogenesis of chronic rejection of human lung allografts |
| Q26827623 | An important role for autoimmunity in the immunopathogenesis of chronic allograft rejection |
| Q41826811 | An obligatory role for lung infiltrating B cells in the immunopathogenesis of obliterative airway disease induced by antibodies to MHC class I molecules |
| Q37654350 | Analysis of Sera of Recipients with Allograft Rejection Indicates That Keratin 1 Is the Target of Anti-Endothelial Antibodies |
| Q50090621 | Anti-tubulin-α-1C autoantibody in systemic lupus erythematosus: a novel indicator of disease activity and vasculitis manifestations |
| Q24630502 | Anti-type V collagen humoral immunity in lung transplant primary graft dysfunction |
| Q36131035 | Antibodies to K-α 1 tubulin and collagen V are associated with chronic rejection after lung transplantation |
| Q42126102 | Antibodies to MHC class I induce autoimmunity: role in the pathogenesis of chronic rejection. |
| Q36206262 | Antibodies to Self-Antigens Predispose to Primary Lung Allograft Dysfunction and Chronic Rejection |
| Q37629539 | Antihuman leukocyte antigen antibody-induced autoimmunity: role in chronic rejection |
| Q37414746 | Autoantibody formation in human and rat studies of chronic rejection and primary graft dysfunction |
| Q45763669 | Autoimmune Reactivity in Graft Injury: Player or Bystander? |
| Q37528715 | Autologous and Allogenous Antibodies in Lung and Islet Cell Transplantation. |
| Q38920115 | Basement membranes and autoimmune diseases |
| Q38158569 | Biomarkers of pulmonary rejection |
| Q37420072 | Bronchiolitis obliterans in lung transplantation: the good, the bad, and the future |
| Q94476143 | Bronchiolitis obliterans syndrome and restrictive allograft syndrome after lung transplantation: why are there two distinct forms of chronic lung allograft dysfunction? |
| Q36623201 | Bronchiolitis obliterans syndrome: the Achilles' heel of lung transplantation |
| Q38081174 | CD4(+) T-cell subsets in transplantation |
| Q34238488 | Characterization of immune responses to cardiac self-antigens myosin and vimentin in human cardiac allograft recipients with antibody-mediated rejection and cardiac allograft vasculopathy |
| Q37867763 | Chronic allograft dysfunction |
| Q38058746 | Chronic lung allograft dysfunction after lung transplantation: the moving target |
| Q38346048 | Chronic rejection of a lung transplant is characterized by a profile of specific autoantibodies |
| Q38053174 | Chronic rejection: a significant role for Th17-mediated autoimmune responses to self-antigens |
| Q55420686 | Circulating immune complexome analysis identified anti-tubulin-α-1c as an inflammation associated autoantibody with promising diagnostic value for Behcet's Disease. |
| Q39015291 | Clinical and immunological relevance of antibodies in solid organ transplantation |
| Q38978203 | Comprehensive Care of the Lung Transplant Patient |
| Q36547137 | Critical role for IL-17A/F in the immunopathogenesis of obliterative airway disease induced by Anti-MHC I antibodies. |
| Q41226640 | Detection of antibodies to self-antigens (K-alpha 1 tubulin, collagen I, II, IV, and V, myosin, and vimentin) by enzyme-linked immunosorbent assay (ELISA). |
| Q33867260 | Development of antibodies to human leukocyte antigen precedes development of antibodies to major histocompatibility class I-related chain A and are significantly associated with development of chronic rejection after human lung transplantation |
| Q57166311 | Diagnosis, Pathophysiology and Experimental Models of Chronic Lung Allograft Rejection |
| Q51040316 | Differential Role of B Cells and IL-17 Versus IFN-γ During Early and Late Rejection of Pig Islet Xenografts in Mice. |
| Q48052794 | Donor-Derived Exosomes With Lung Self-Antigens in Human Lung Allograft Rejection |
| Q42140181 | Donor-derived exosomes: key in lung allograft rejection? |
| Q41703961 | Dysregulated MicroRNA Expression and Chronic Lung Allograft Rejection in Recipients With Antibodies to Donor HLA. |
| Q34036197 | Efficacy of extracorporeal photopheresis in clearance of antibodies to donor-specific and lung-specific antigens in lung transplant recipients. |
| Q50117728 | Exosomes Expressing the Self-Antigens Myosin and Vimentin Play an Important Role in Syngeneic Cardiac Transplant Rejection Induced by Antibodies to Cardiac Myosin |
| Q28395914 | HIF-1α signaling by airway epithelial cell K-α1-tubulin: role in fibrosis and chronic rejection of human lung allografts |
| Q36703898 | Humoral immunity and the development of obliterative bronchiolitis after lung transplantation: is there a link? |
| Q39121365 | Immune Responses to Tissue-Restricted Nonmajor Histocompatibility Complex Antigens in Allograft Rejection |
| Q36979114 | Immune response to extracellular matrix collagen in chronic hepatitis C-induced liver fibrosis |
| Q38110566 | Immune responses to self-antigens (autoimmunity) in allograft rejection |
| Q35918692 | Immune responses to self-antigens in asthma patients: clinical and immunopathological implications |
| Q37325196 | Immunobiology of chronic lung allograft dysfunction: new insights from the bench and beyond |
| Q38154197 | Immunosuppression and allograft rejection following lung transplantation: evidence to date |
| Q92033719 | Impact of pretransplant antibodies on outcomes after heart transplantation |
| Q36999202 | Implications for human leukocyte antigen antibodies after lung transplantation: a 10-year experience in 441 patients. |
| Q33756027 | Increased erythrocyte C4D is associated with known alloantibody and autoantibody markers of antibody-mediated rejection in human lung transplant recipients |
| Q36292047 | Inhibition of renin angiotensin aldosterone system causes abrogation of obliterative airways disease through inhibition of tumor necrosis factor-α-dependant interleukin-17. |
| Q34462078 | Innate immune activation by the viral PAMP poly I:C potentiates pulmonary graft-versus-host disease after allogeneic hematopoietic cell transplant |
| Q38123309 | Interplay between immune responses to HLA and non-HLA self-antigens in allograft rejection |
| Q37184035 | Late primary graft dysfunction after lung transplantation and bronchiolitis obliterans syndrome |
| Q56341944 | Leukocyte-Associated Ig-like Receptor 1 Inhibits T1 Responses but Is Required for Natural and Induced Monocyte-Dependent T17 Responses |
| Q34079646 | Lipid raft facilitated ligation of K-alpha1-tubulin by specific antibodies on epithelial cells: Role in pathogenesis of chronic rejection following human lung transplantation |
| Q37836540 | Loss of tolerance to self after transplant |
| Q40668499 | Lung Injury Combined with Loss of Regulatory T Cells Leads to De Novo Lung-Restricted Autoimmunity |
| Q50069723 | Lung Injury and Loss of Regulatory T Cells Primes for Lung-Restricted Autoimmunity |
| Q38224758 | Lung transplantation: chronic allograft dysfunction and establishing immune tolerance |
| Q41631328 | Lung-Restricted Antibodies Mediate Primary Graft Dysfunction and Prevent Allotolerance after Murine Lung Transplantation |
| Q88510794 | Magnetisation transfer as a biomarker for chronic airway fibrosis in a mouse lung transplantation model |
| Q39432095 | Managing bronchiolitis obliterans syndrome (BOS) and chronic lung allograft dysfunction (CLAD) in children: what does the future hold? |
| Q35952077 | MicroRNA-144 dysregulates the transforming growth factor-β signaling cascade and contributes to the development of bronchiolitis obliterans syndrome after human lung transplantation |
| Q38123310 | Moving beyond HLA: a review of nHLA antibodies in organ transplantation |
| Q34874203 | Neutralizing IL-17 prevents obliterative bronchiolitis in murine orthotopic lung transplantation |
| Q34259047 | Non-MHC antigenic targets of the humoral immune response in transplantation |
| Q37505394 | Obliterative bronchiolitis following lung transplantation: from old to new concepts? |
| Q28661021 | Overview of clinical lung transplantation |
| Q37149537 | Pre-transplant antibodies to Kα1 tubulin and collagen-V in lung transplantation: clinical correlations |
| Q91834605 | Prevalence of antibodies to lung self-antigens (Kα1 tubulin and collagen V) and donor specific antibodies to HLA in lung transplant recipients and implications for lung transplant outcomes: Single center experience |
| Q37313051 | Report from a consensus conference on antibody-mediated rejection in heart transplantation |
| Q36206278 | Respiratory Virus-Induced Dysregulation of T-Regulatory Cells Leads to Chronic Rejection |
| Q89600511 | Respiratory viral infection in lung transplantation induces exosomes that trigger chronic rejection |
| Q37622866 | Role of Th17 cells and IL-17 in lung transplant rejection |
| Q41226453 | Role of alloimmunity and autoimmunity in allograft rejection |
| Q38025804 | Role of antibodies to self-antigens in chronic allograft rejection: potential mechanism and therapeutic implications |
| Q33570756 | Role of defensins in the pathogenesis of chronic lung allograft rejection |
| Q39689040 | Role of interleukin-17A in early graft rejection after orthotopic lung transplantation in mice |
| Q26998887 | Significance of T helper 17 immunity in transplantation |
| Q38738172 | Significant role for microRNA-21 affecting toll-like receptor pathway in primary graft dysfunction after human lung transplantation |
| Q48513546 | Specific Donor HLA-DR Types Correlate with Altered Susceptibility to Development of Chronic Lung Allograft Dysfunction |
| Q41966454 | T regulatory cells play a significant role in modulating MHC class I antibody-induced obliterative airway disease. |
| Q39228029 | Th17 Responses to Collagen Type V, kα1-Tubulin, and Vimentin Are Present Early in Human Development and Persist Throughout Life |
| Q61814286 | The Autoimmune-Associated Single Nucleotide Polymorphism Within Correlates With Clinical Outcome After Lung Transplantation |
| Q52934357 | The efficacy of prophylactic azithromycin on bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation. |
| Q86635362 | The impact of non-HLA antibodies directed against endothelin-1 type A receptors (ETAR) on early renal transplant outcomes |
| Q27008934 | The role of autoimmunity in obliterative bronchiolitis after lung transplantation |
| Q51551640 | The role of soluble and insoluble gastric fluid components in the pathogenesis of obliterative bronchiolitis in rat lung allografts. |
| Q90747606 | Update on Bronchiolitis Obliterans Syndrome in Lung Transplantation |
| Q93074073 | WITHDRAWN: [Non anti-HLA antibodies and acute rejection: A critical viewpoint] |
| Q51697694 | Why is the patient out of breath? Collagen V(α1) and K-α1-tubulin take center stage in lung transplantation. |
Search more.